文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

重症COVID-19患者皮肤微血管内皮反应性受损

Impaired skin microvascular endothelial reactivity in critically ill COVID-19 patients.
PubMed 文献 · Ann Intensive Care · 2022-06-13
一句话结论重症COVID-19患者皮肤微血管基础血流及内皮依赖性反应性较非COVID-19细菌性肺炎患者显著降低,提示SARS-CoV-2对内皮的特定致病作用。

本单中心初步观察性研究纳入32例COVID-19患者和11例非COVID-19细菌性肺炎(NCBP)对照患者,均伴急性呼吸衰竭,采用乙酰胆碱离子导入联合激光多普勒评估微血管内皮反应性。COVID-19组皮肤微血管基础血流显著低于NCBP组(P=0.02),内皮依赖性微血管反应性仅为NCBP组的三分之一(P=0.008)。尽管COVID-19组SAPS II评分更低,但内皮功能受损更明显,支持SARS-CoV-2对内皮的特定致病作用。

要点

  • 重症COVID-19患者皮肤微血管基础血流显著低于NCBP患者(P=0.02)。
  • 重症COVID-19患者内皮依赖性微血管反应性较NCBP患者低三倍(P=0.008)。
  • COVID-19组SAPS II评分低于NCBP组(P<0.0001),但SOFA评分无差异(P=0.51)。
  • 两组整体血流动力学和外周组织灌注参数无差异。
  • 提示SARS-CoV-2可能对内皮有特定致病作用,独立于疾病严重程度。

适用人群与场景

  • 重症COVID-19患者(n=32)与急性呼吸衰竭的非COVID-19细菌性肺炎(NCBP)患者(n=11),来自单中心,连续三个月纳入。

研究设计与关键结果

  • 研究类型:单中心初步观察性研究;样本量:COVID-19组32例,NCBP组11例。
  • 中位年龄:COVID-19组59[50-68]岁,NCBP组69[57-75]岁(P=0.11)。
  • 合并症或用药无显著差异,但COVID-19组体重指数更高。
  • SAPS II评分:NCBP组高于COVID-19组(P<0.0001);SOFA评分组间无差异(P=0.51)。
  • 整体血流动力学和外周组织灌注参数组间无差异。
  • 皮肤微血管基础血流:COVID-19组显著低于NCBP组(P=0.02)。
  • 内皮依赖性微血管反应性:COVID-19组较NCBP组低三倍(P=0.008)。

证据类型、等级与局限

  • 证据类型:单中心初步观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Some clinical and histological studies have reported that SARS-CoV-2 infection may damage the endothelium. However, the impact of this virus on endothelial function in vivo remains poorly characterized. In this single-center pilot observational study, we performed iontophoresis of acetylcholine coupled with Laser doppler to investigate microvascular endothelial reactivity in COVID-19 patients compared to patients with non-COVID-19 bacterial pneumonia (NCBP) patients.

RESULTS: During three consecutive months, 32 COVID-19 patients and 11 control NCBP patients with acute respiratory failure were included. The median age was 59 [50-68] and 69 [57-75] years in COVID-19 and NCBP groups, respectively (P = 0.11). There was no significant difference in comorbidities or medications between the two groups, except for body mass index, which was higher in COVID-19 patients. NCBP patients had a higher SAPS II score compared to COVID-19 patients (P < 0.0001), but SOFA score was not different between groups (P = 0.51). Global hemodynamic and peripheral tissue perfusion parameters were not different between groups. COVID-19 patients had significantly lower skin microvascular basal blood flow than NCBP patients (P = 0.02). In addition, endothelium-dependent microvascular reactivity was threefold lower in COVID-19 patients than NCBP patients (P = 0.008).

CONCLUSIONS: Both baseline skin microvascular blood flow and skin endothelial-dependent microvascular reactivity were impaired in critically ill COVID-19 patients compared to NCBP patients, despite a lower disease severity score supporting a specific pathogenic role of SARS-CoV-2 on the endothelium.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Raia L, Urbina T, Gabarre P, et al. Impaired skin microvascular endothelial reactivity in critically ill COVID-19 patients. Ann Intensive Care. 2022. PMID: 35696007. doi:10.1186/s13613-022-01027-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。